HFS
IMNM icon

Hughes Financial Services’s Immunome IMNM Stock Holding History

Hughes Financial Services’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233 Buy
11
+10
+1,000% +$214 ﹤0.01% 1247
2026
Q1 		$22 Buy
+1
New +$22 ﹤0.01% 1598

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Hughes Financial Services's IMNM Position: Q2 2026 in Review

Hughes Financial Services increased its Immunome (IMNM) stake by 1,000% in Q2 2026, buying an estimated $214 and bringing the position to 11 shares worth $233. The position accounts for ﹤0.01% of the portfolio, ranked #1247.

Hughes Financial Services first reported a position in IMNM in Q1 2026 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Hughes Financial Services held 11 shares of Immunome worth $233 as of Q2 2026.
  • Hughes Financial Services bought 10 Immunome shares in Q2 2026, an estimated $214.
  • Immunome made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1247 holding.
  • Hughes Financial Services first reported a position in Immunome in Q1 2026 and has held it in 2 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.